Cover Image
市場調查報告書

Pacific Therapeutics Ltd.的產品平台分析

Pacific Therapeutics Ltd. - Product Pipeline Review - 2014

出版商 Global Markets Direct 商品編碼 321982
出版日期 內容資訊 英文 23 Pages
訂單完成後即時交付
價格
Back to Top
Pacific Therapeutics Ltd.的產品平台分析 Pacific Therapeutics Ltd. - Product Pipeline Review - 2014
出版日期: 2014年12月24日 內容資訊: 英文 23 Pages
簡介

Pacific Therapeutics Ltd.是總公司設立於加拿大的製藥企業。從事著肝疾病及肺部疾病治療所用的藥物候補之特定,開發,銷售。該公司的產品──PTL-202用於治療突發性肺纖維化,PTL-303則是正在臨床試驗中的肝硬化治療藥。該公司產品正在美國等國家銷售中。

本報告提供Pacific Therapeutics Ltd. 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Pacific Therapeutics Ltd. 的基本資料

  • Pacific Therapeutics Ltd. 概要
  • 主要資訊
  • 企業資料

Pacific Therapeutics Ltd. :R&D概要

  • 主要的治療範圍

Pacific Therapeutics Ltd. :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式

Pacific Therapeutics Ltd. :開發中產品概況

  • 臨床階段的開發中產品
    • 第一階段的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
  • 開發階段不明的開發中產品
    • 開發階段不明的產品/聯合治療模式

Pacific Therapeutics Ltd. :藥物簡介

  • (pentoxifylline + acetylcysteine)
  • PTL-303
  • sildenafil citrate

Pacific Therapeutics Ltd. :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Pacific Therapeutics Ltd. :最新的開發平台資訊

Pacific Therapeutics Ltd. :中止開發的計劃

Pacific Therapeutics Ltd. :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

目錄
Product Code: GMDHC06731CDB

Summary

Global Markets Direct's, 'Pacific Therapeutics Ltd. - Product Pipeline Review - 2014', provides an overview of the Pacific Therapeutics Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Pacific Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Pacific Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Pacific Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Pacific Therapeutics Ltd.'s pipeline products

Reasons to buy

  • Evaluate Pacific Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Pacific Therapeutics Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Pacific Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Pacific Therapeutics Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Pacific Therapeutics Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Pacific Therapeutics Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Pacific Therapeutics Ltd. Snapshot
    • Pacific Therapeutics Ltd. Overview
    • Key Information
    • Key Facts
  • Pacific Therapeutics Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Pacific Therapeutics Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
  • Pacific Therapeutics Ltd. - Pipeline Products Glance
    • Pacific Therapeutics Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Pacific Therapeutics Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
    • Pacific Therapeutics Ltd. - Unknown Stage Pipeline Products
      • Unknown Products/Combination Treatment Modalities
  • Pacific Therapeutics Ltd. - Drug Profiles
    • (pentoxifylline + acetylcysteine)
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • PTL-303
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • sildenafil citrate
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Pacific Therapeutics Ltd. - Pipeline Analysis
    • Pacific Therapeutics Ltd. - Pipeline Products by Target
    • Pacific Therapeutics Ltd. - Pipeline Products by Route of Administration
    • Pacific Therapeutics Ltd. - Pipeline Products by Molecule Type
    • Pacific Therapeutics Ltd. - Pipeline Products by Mechanism of Action
  • Pacific Therapeutics Ltd. - Recent Pipeline Updates
  • Pacific Therapeutics Ltd. - Dormant Projects
  • Pacific Therapeutics Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Pacific Therapeutics Ltd., Key Information
  • Pacific Therapeutics Ltd., Key Facts
  • Pacific Therapeutics Ltd. - Pipeline by Indication, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Stage of Development, 2014
  • Pacific Therapeutics Ltd. - Monotherapy Products in Pipeline, 2014
  • Pacific Therapeutics Ltd. - Combination Treatment Modalities in Pipeline, 2014
  • Pacific Therapeutics Ltd. - Phase I, 2014
  • Pacific Therapeutics Ltd. - Preclinical, 2014
  • Pacific Therapeutics Ltd. - Unknown, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Target, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Route of Administration, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Molecule Type, 2014
  • Pacific Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2014
  • Pacific Therapeutics Ltd. - Recent Pipeline Updates, 2014
  • Pacific Therapeutics Ltd. - Dormant Developmental Projects,2014

List of Figures

  • Pacific Therapeutics Ltd. - Pipeline by Top 10 Indication, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Stage of Development, 2014
  • Pacific Therapeutics Ltd. - Monotherapy Products in Pipeline, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Top 10 Target, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Pacific Therapeutics Ltd. - Pipeline by Top 10 Molecule Type, 2014
  • Pacific Therapeutics Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2014
Back to Top